Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation during Cardiac Surgery - Reply

Xiaoxi Yao; Peter A. Noseworthy

doi:10.1001/jama.2018.11341

Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation during Cardiac Surgery - Reply

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1602-1603
Number of pages	2
Journal	JAMA - Journal of the American Medical Association
Volume	320
Issue number	15
DOIs	https://doi.org/10.1001/jama.2018.11341
State	Published - Oct 16 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2018.11341

Cite this

@article{ae8c458a8a724d10a87e671b25831756,

title = "Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation during Cardiac Surgery - Reply",

author = "Xiaoxi Yao and Noseworthy, {Peter A.}",

note = "Funding Information: Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gleason reported receiving grants from Medtronic, Boston Scientific, and Cytosorb and receiving personal fees from Abbott (St Jude Medical) and Cytosorb. Dr Chu reported receiving personal fees from the Osler Institute, Wolters Kluwer Health, Quality Insights Inc, Toray International America Inc, Japanese Organization for Medical Device Development Inc, and Terumo Cardiovascular Systems Corp. No other disclosures were reported.",

year = "2018",

month = oct,

day = "16",

doi = "10.1001/jama.2018.11341",

language = "English (US)",

volume = "320",

pages = "1602--1603",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "15",

}

TY - JOUR

T1 - Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation during Cardiac Surgery - Reply

AU - Yao, Xiaoxi

AU - Noseworthy, Peter A.

N1 - Funding Information: Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gleason reported receiving grants from Medtronic, Boston Scientific, and Cytosorb and receiving personal fees from Abbott (St Jude Medical) and Cytosorb. Dr Chu reported receiving personal fees from the Osler Institute, Wolters Kluwer Health, Quality Insights Inc, Toray International America Inc, Japanese Organization for Medical Device Development Inc, and Terumo Cardiovascular Systems Corp. No other disclosures were reported.

PY - 2018/10/16

Y1 - 2018/10/16

UR - http://www.scopus.com/inward/record.url?scp=85054993363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054993363&partnerID=8YFLogxK

U2 - 10.1001/jama.2018.11341

DO - 10.1001/jama.2018.11341

M3 - Letter

C2 - 30326120

AN - SCOPUS:85054993363

SN - 0098-7484

VL - 320

SP - 1602

EP - 1603

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 15

ER -

Left Atrial Appendage Occlusion and Surgical Ablation for Atrial Fibrillation during Cardiac Surgery - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this